TRANSDERMAL CANCER ANTIGEN PEPTIDE PREPARATION

• 收藏
• 分享

专利权人:

LTD.;SUMITOMO DAINIPPON PHARMA CO.

发明人:

Masayasu Tanaka,Kazumitsu Yamamoto,Hiroo Maeda,Koichi Saito,Natsuko Suginobe

申请号：

US14412148

公开号：

US20150150975A1

申请日:

2013.07.02

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The invention enables more efficient CTL induction by applying a transdermal preparation containing a WT1 protein-derived cancer antigen peptide and an ether-type additive, which is liquid at 20° C., to a WT1 protein-derived cancer antigen peptide. The ether-type additive is represented by the formula (1): R1—O—R2 (1), wherein R1 is a hydrocarbon group having 8-24 carbon atoms, and R2 is a group represented by the formula (2):or a group represented by the formula (3): —(CH2CH2O)mH (3), wherein m is an integer of 1-18.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/